Washington Vertex Pharmaceuticals - Search News

Vertex Stock Jumps

CNBC on MSN · 19h

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

Investopedia on MSN · 3h

Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain."

Washington Times · 10m

FDA approves suzetrigine, the first new painkiller since 1998

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.

4hon MSN

FDA OK's painkiller designed to end opioids' addiction and overdose risk

Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...

2h

Vertex Pharmaceuticals Shares Are Up Today: What's Going On?

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...

2h

Vertex Pharmaceuticals price target raised to $545 from $520 at BMO Capital

BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...

22hon MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results